ARTICLE

PREGNANCYRELATED THYROID DYSFUNCTION AND ITS EFFECTS A SINGLECENTER STUDY

  1. HOME
  2. ARTICLE

09 Pages : 60-64

http://dx.doi.org/10.31703/gpsr.2023(VIII-I).09      10.31703/gpsr.2023(VIII-I).09      Published : Mar 2023

Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study

Abstract

    This research aimed to evaluate the consequences of pregnancy-related thyroid dysfunction on 100 participants. All patients had their thyroid stimulating hormone (TSH), free thyroxine (FT3), and free triiodothyronine (FT4) measured before, during, and after pregnancy. Thyroid hormones and neck ultrasounds were also performed. According to the research, 86.0% of pregnant women had abnormal TSH levels. Of them, 28% had TSH levels over 4.2mIU/L, and 10% had values in the 2.5–4.2mIU/L range. Most patients' FT3 and FT4 levels were within the normal range during pregnancy. Most patients (59%) had postpartum thyroid dysfunction; ultrasonography demonstrated goitre in 56% of patients and cystic lesions in 8%. TSH concentrations between 2.5 and 4.2 mIU/L and higher than 4.2 mIU/L were found in 14% and 36% of individuals, respectively. According to the study's findings, pregnancy-related thyroid dysfunction is a prevalent illness in the population under investigation. It may dramatically impact both the mother's and the baby's health.

    Pregnancy-Related Thyroid Dysfunction, TSH, FT3, FT4, Ultrasonography

    (1) Muhammad Hussain Afridi
    Assistant Professor, Department of Diabetes and Endocrinology, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
    (2) Tahir Ghaffar
    Assistant Professor, Department of Diabetes and Endocrinology, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
    (3) Itizaz Hayat
    Post-graduate Resident, Department of General Medicine, Hayatabad Medical Complex, Peshawar, KP, Pakistan.
    (4) Mohammad Khalid Khan
    Associate Professor, Department of Community Medicine, Gajju Khan Medical College, Swabi, KP, Pakistan.
    (5) Wiqas Ahmad
    Specialist Registrar, Department of Gastroenterology, MTI-Hayatabad Medical Complex, Peshawar, KP, Pakistan.
Fulltext PDF

References

  • Altomare, M., Vignera, S. L., Asero, P., Recupero, D., Condorelli, R. A., Scollo, P., Gulisano, A., Magro, E., Tumino, D., Tumino, S., Vicari, E., Leanza, V., D’Agata, R., & Calogero. (2013). High prevalence of thyroid dysfunction in pregnant women. Journal of Endocrinological Investigation, 36(6), 407–411. https://doi.org/10.3275/8658
  • Fitzpatrick, D. L., & Russell, M. A. (2010). Diagnosis and Management of Thyroid Disease in Pregnancy. Obstetrics and Gynecology Clinics of North America, 37(2), 173–193. https://doi.org/10.1016/j.ogc.2010.02.007
  • Gallas, P., Stolk, R., Bakker, K., Endert, E., & Wiersinga, W. (2002). Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. European Journal of Endocrinology, 147(4), 443–451. https://doi.org/10.1530/eje.0.1470443
  • Glinoer, D. (1997). The Regulation of Thyroid Function in Pregnancy: Pathways of Endocrine Adaptation from Physiology to Pathology. Endocrine Reviews, 18(3), 404– 433. https://doi.org/10.1210/edrv.18.3.0300
  • Kumar, V., & Singh, R. K. (2020). A cross-sectional study to investigate the prevalence and etiology of different thyroid disorders in PCOS patients. European Journal of Molecular & Clinical Medicine (EJMCM), 7(10).
  • Leung, A. S., Millar, L. K., Koonings, P. P., Montoro, M., & Mestman, J. H. (1993). Perinatal outcome in hypothyroid pregnancies. International Journal of Gynecology & Obstetrics, 43(2), 230–230. https://doi.org/10.1016/0020-7292(93)90343-u
  • Männistö, T., Mendola, P., Reddy, U., & Laughon, S. K. (2013). Neonatal Outcomes and Birth Weight in Pregnancies Complicated by Maternal Thyroid Disease. American Journal of Epidemiology, 178(5), 731–740. https://doi.org/10.1093/aje/kwt031
  • Mannisto, T., VääräsmäkiM., Pouta, A., Hartikainen, A., Ruokonen, A., Surcel, H., Bloigu, A., JärvelinM., & Suvanto, E. (2010). Thyroid Dysfunction and Autoantibodies during Pregnancy as Predictive Factors of Pregnancy Complications and Maternal Morbidity in Later Life. The Journal of Clinical Endocrinology & Metabolism, 95(3), 1084–1094. https://doi.org/10.1210/jc.2009-1904
  • Millar, L. K., Wing, D. A., Leung, A. S., Koonings, P. P., Montoro, M. N., & Mestman, J. H. (1994). Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. (1995). International Journal of Gynecology & Obstetrics, 50(2), 223–223. https://doi.org/10.1016/0020-7292(95)94890-r
  • Okosieme, O. E., & Lazarus, J. H. (2010). Thyroid dysfunction in pregnancy: optimizing fetal and maternal outcomes. Expert Review of Endocrinology & Metabolism, 5(4), 521–529. https://doi.org/10.1586/eem.10.30
  • Poppe, K. (2003). Thyroid autoimmunity and hypothyroidism before and during pregnancy. Human Reproduction Update, 9(2), 149–161. https://doi.org/10.1093/humupd/dmg012
  • Skjöldebrand, L., Brundin, J., Carlström, A., & Pettersson, T. (1982). Thyroid associated components in serum during normal pregnancy. Acta Endocrinologica, 100(4), 504–511. https://doi.org/10.1530/acta.0.1000504
  • Stagnaro-Green, A. (2009). Maternal Thyroid Disease and Preterm Delivery. The Journal of Clinical Endocrinology & Metabolism, 94(1), 21– 25. https://doi.org/10.1210/jc.2008-1288
  • Surks, M. I., Ortiz, E., Daniels, G. H., Sawin, C. T., Col, N. F., Cobin, R. H., Franklyn, J. A., Hershman, J. M., Burman, K. D., Denke, M. A., Gorman, C., Cooper, R. S., & Weissman, N. J. (2004). Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA, 291(2), 228–238. https://doi.org/10.1001/jama.291.2.228
  • Vanderpump, M. P. J., & Tunbridge, W. M. G. (2002). Epidemiology and Prevention of Clinical and Subclinical Hypothyroidism. Thyroid, 12(10), 839–847. https://doi.org/10.1089/105072502761016458

Cite this article

APA

    APA : Afridi, M. H., Ghaffar, T., & Hayat, I. (2023). Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study. Global Pharmaceutical Sciences Review, VIII(I), 60-64. https://doi.org/10.31703/gpsr.2023(VIII-I).09

CHICAGO

    CHICAGO : Afridi, Muhammad Hussain, Tahir Ghaffar, and Itizaz Hayat. 2023. "Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study." Global Pharmaceutical Sciences Review, VIII (I): 60-64 doi: 10.31703/gpsr.2023(VIII-I).09

HARVARD

    HARVARD : AFRIDI, M. H., GHAFFAR, T. & HAYAT, I. 2023. Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study. Global Pharmaceutical Sciences Review, VIII, 60-64.

MHRA

    MHRA : Afridi, Muhammad Hussain, Tahir Ghaffar, and Itizaz Hayat. 2023. "Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study." Global Pharmaceutical Sciences Review, VIII: 60-64

MLA

    MLA : Afridi, Muhammad Hussain, Tahir Ghaffar, and Itizaz Hayat. "Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study." Global Pharmaceutical Sciences Review, VIII.I (2023): 60-64 Print.

OXFORD

    OXFORD : Afridi, Muhammad Hussain, Ghaffar, Tahir, and Hayat, Itizaz (2023), "Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study", Global Pharmaceutical Sciences Review, VIII (I), 60-64

TURABIAN

    TURABIAN : Afridi, Muhammad Hussain, Tahir Ghaffar, and Itizaz Hayat. "Pregnancy-Related Thyroid Dysfunction And Its Effects A Single-Center Study." Global Pharmaceutical Sciences Review VIII, no. I (2023): 60-64. https://doi.org/10.31703/gpsr.2023(VIII-I).09